<?xml version="1.0" encoding="UTF-8"?>
<results title="funders">
 <result pre="MERS-CoV clinical isolate and screened 5,406 compounds, including United States" exact="Food and Drug Administration" post="(FDA)-approved drugs and bioactive molecules, for their activity against"/>
 <result pre="major outbreak occurred in South Korea in 2015 ( Korea" exact="Centers for Disease Control and Prevention," post="2015; Yang et al., 2015). Notably, aside from the"/>
 <result pre="186 confirmed cases across 16 clinics ( Cho, 2015; Korea" exact="Centers for Disease Control and Prevention," post="2015). Furthermore, continuous waves of MERS outbreaks in the"/>
 <result pre="outbreaks in the Middle East have been reported by the" exact="World Health Organization" post="(WHO), although they have been smaller than the major"/>
 <result pre="have been reported (March 19, 2020). Unfortunately, CoV-specific United States" exact="Food and Drug Administration" post="(FDA)-approved drugs are still not available in clinics. To"/>
 <result pre="Supplementary Table 1 Acknowledgments This research was supported by the" exact="National Research Foundation" post="(NRF) of Korea, which is funded by the Ministry"/>
 <result pre="J Clin Basic Cardiol 2, 169– 174. OpenUrl ↵ Korea" exact="Centers for Disease Control and Prevention," post="2015. Middle East Respiratory Syndrome Coronavirus Outbreak in the"/>
 <result pre="November 2002 to 31 July 2003 [WWW Document]. URL http://www.who.int/csr/sars/country/table2004_04_21/en/" exact="World Health Organization," post="Novel coronavirus (2019-nCoV). https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed 26 February 2020. ↵"/>
</results>
